Day One Biopharmaceuticals Inc (DAWN) stock news · rev $131.2M
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
This DAWN news page leads with what Day One Biopharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for DAWN yet. We will not pad this page with generic market recap.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DAWN stock page; for the tape open the quote page.
Not investment advice.